You’ve probably read the news stories about a recent outbreak of meningitis in 19 states. So far this outbreak has caused 25 deaths as well as 354 cases of serious illness. The Centers for Disease Control traced the outbreak’s origin to contaminated steroids from a Massachusetts-based compounding pharmacy.
The contamination resulted from the compounding pharmacy’s attempt at high-volume drug production using inadequate facilities, equipment and practices. As more information about compounding pharmacies’ practices comes to light, I’m wondering why better standards and operating procedures, supported by clear documentation, are not in place at these facilities.